AHP/Interneuron Redux NEJM editorial reiterates authors' advisory cmte. presentations for sponsors.

Executive Summary

REDUX NEJM EDITORIAL REITERATES ADVISORY CMTE. PRESENTATIONS made by the authors of the editorial, JoAnn Manson, MD/PhD, Harvard Medical School, and former FDA Office of Epidemiology and Biostatistics Director Gerald Faich, MD, University of Pennsylvania, during the Sept. 28 and Nov. 16 review of Wyeth-Ayerst/Interneuron's obesity therapy Redux (dexfenfluramine). Manson and Faich have been criticized for failing to properly disclose their consulting arrangements with Wyeth and Interneuron to the New England Journal of Medicine.